drugset / Trial / NCT01006018
DPP-4 Inhibition and TZD for DM Prevention
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To determine whether treatment with the diabetes medication, Januvia (sitagliptin), with or without another diabetes medicine, Actos (pioglitazone), will improve insulin secretion and insulin response individuals with Impaired Glucose Tolerance (IGT), a form of prediabetes.
Timeline
- Start
- 2011-07
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 15 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |